Expression of β-catenin is necessary for physiological growth of adult skeletal muscle

American Journal of Physiology - Cell Physiology

Volumn 291, Issue 1, 2006, Pages

  Armstrong, Dustin D ^a,c   Wong, Vicki L ^a   Esser, Karyn A ^a,b  

^a UNIVERSITY OF KENTUCKY   (United States)

^b Dept of Physiology   (United States)

^c NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH   (United States)

Author keywords

Hypertrophy; Overload; Wnt

Indexed keywords

BETA CATENIN; CRE RECOMBINASE;

ARTICLE; GROWTH INHIBITION; MUSCLE GROWTH; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKELETAL MUSCLE; VIRAL GENE DELIVERY SYSTEM;

ANIMALS; BETA CATENIN; GENE EXPRESSION REGULATION; MICE; MICE, TRANSGENIC; MUSCLE, SKELETAL;

ADENOVIRIDAE;

EID: 33745686080     PISSN: 03636143     EISSN: 15221563     Source Type: Journal    
DOI: 10.1152/ajpcell.00644.2005     Document Type: Article

References (16)

1. Adams GR and Haddad F. The relationships among IGF-1, DNA content, and protein accumulation during skeletal muscle hypertrophy. J Appl Physiol 81: 2509-2516, 1996.
2. Armstrong DD and Esser KA. Wnt/β-catenin signaling activates growth-control genes during overload-induced skeletal muscle hypertrophy. Am J Physiol Cell Physiol 289: C853-C859, 2005.
3. Barton-Davis ER, Shoturma DI, and Sweeney HL. Contribution of satellite cells to IGF-I induced hypertrophy of skeletal muscle. Acta Physiol Scand 167: 301-305, 1999.
4. Bax B, Carter PS, Lewis C, Guy AR, Bridges A, Tanner R, Pettman G, Mannix C, Culbert AA, Brown MJ, Smith DG, and Reith AD. The structure of phosphorylated GSK-3β complexed with a peptide, FRAT-tide, that inhibits β-catenin phosphorylation. Structure 9: 1143-1152, 2001.
5. Bodine SC, Stitt TN, Gonzalez M, Kline WO, Stover GL, Bauerlein R, Zlotchenko E, Scrimgeour A, Lawrence JC, Glass DJ, and Yancopoulos GD. Akt/mTOR pathway is a crucial regulator of skeletal muscle hypertrophy and can prevent muscle atrophy in vivo. Nat Cell Biol 3: 1014-1019, 2001.
6. Cossu G and Borello U. Wnt signaling and the activation of myogenesis in mammals. EMBO J 18: 6867-6872, 1999.
7. Desbois-Mouthon C, Cadoret A, Blivet-Van Eggelpoel MJ, Bertrand F, Cherqui G, Perret C, and Capeau J. Insulin and IGF-1 stimulate the β-catenin pathway through two signalling cascades involving GSK-3β inhibition and Ras activation. Oncogene 20: 252-259, 2001.
8. Goldberg AL, Etlinger JD, Goldspink DF, and Jablecki C. Mechanism of work-induced hypertrophy of skeletal muscle. Med Sci Sports 7: 185-198, 1975.
9. Haq S, Michael A, Andreucci M, Bhattacharya K, Dotto P, Walters B, Woodgett J, Kilter H, and Force T. Stabilization of β-catenin by a Wnt-independent mechanism regulates cardiomyocyte growth. Proc Natl Acad Sci USA 100: 4610-4615, 2003.
10. Huard J, Lochmuller H, Acsadi G, Jani A, Holland P, Guerin C, Massie B, and Karpati G. Differential short-term transduction efficiency of adult versus newborn mouse tissues by adenoviral recombinants. Exp Mol Pathol 62: 131-143, 1995.
11. Kim KI, Cho HJ, Hahn JY, Kim TY, Park KW, Koo BK, Shin CS, Kim CH, Oh BH, Lee MM, Park YB, and Kim HS. β-Catenin overexpression augments angiogenesis and skeletal muscle regeneration through dual mechanism of vascular endothelial growth factor-mediated endothelial cell proliferation and progenitor cell mobilization. Arterioscler Thromb Vasc Biol 26: 91-98, 2006.
12. Logan CY and Nusse R. The Wnt signaling pathway in development and disease. Annu Rev Cell Dev Biol 20: 781-810, 2004.
13. Moon RT, Kohn AD, De Ferrari GV, and Kaykas A. WNT and β-catenin signalling: diseases and therapies. Nat Rev Genet 5: 691-701, 2004.
14. Nelson WJ and Nusse R. Convergence of Wnt, β-catenin, and cadherin pathways. Science 303: 1483-1487, 2004.
15. Nusse R. Cell biology: relays at the membrane. Nature 438: 747-749, 2005.
16. Rommel C, Bodine SC, Clarke BA, Rossman R, Nunez L, Stitt TN, Yancopoulos GD, and Glass DJ. Mediation of IGF-1-induced skeletal myotube hypertrophy by PI(3)K/Akt/mTOR and PI(3)K/Akt/GSK3 pathways. Nat Cell Biol 3: 1009-1013, 2001.